Drug Shows Promise in Slowing Progression of Smoldering Myeloma to Cancer


The drug lenalidomide (Revlimid) may delay the progression of smoldering myeloma to multiple myeloma, according to preliminary results from a clinical trial.

Powered by WPeMatico